Ogawa M, Sugawara S, Kunisada T, Sudo T, Hayashi S, Nishikawa S, Kodama H, Nishikawa S
Department of Molecular Genetics, Faculty of Medicine, Kyoto University, Japan.
Exp Hematol. 1998 Jun;26(6):478-88.
The receptor tyrosine kinase Flk-2/Flt3 was originally cloned from hematopoietic stem cell-enriched fetal liver and placenta and is believed by some investigators to play a role in the regulation of the hematopoietic stem cell. However, targeted disruption of the flt3 gene results in a specific deficiency in early B cell progenitors. Using an antagonistic monoclonal antibody developed against the extracellular domain of Flt3, we investigated the expression and function of the molecule on B lymphoid lineage cells in the bone marrow (BM) of adult mice. Approximately 10% of B220+ cells in the BM expressed Flt3 on the cell surface, and most of the cells belonged to a pro-B cell fraction when judged by an expression pattern of CD43, heat-stable antigen, and BP-1. However, B lymphoid precursor cells that are clonable in vitro could not be enriched in the B220+/Flt3+ cell fraction sorted by flow cytometry. Furthermore, proliferation of B lymphoid precursor cells in the adult BM was not blocked by administration of the antagonistic monoclonal antibodies against Flt3 and c-Kit, suggesting that signalings mediated by Flt3 and c-Kit receptors are not essential for the proliferation of B cell progenitors in adult mouse BM.
受体酪氨酸激酶Flk-2/Flt3最初是从富含造血干细胞的胎肝和胎盘中克隆出来的,一些研究人员认为它在造血干细胞的调节中发挥作用。然而,flt3基因的靶向破坏导致早期B细胞祖细胞出现特定缺陷。我们使用针对Flt3细胞外结构域开发的拮抗单克隆抗体,研究了该分子在成年小鼠骨髓(BM)中B淋巴细胞系细胞上的表达和功能。骨髓中约10%的B220+细胞在细胞表面表达Flt3,根据CD43、热稳定抗原和BP-1的表达模式判断,大多数细胞属于前B细胞部分。然而,通过流式细胞术分选的B220+/Flt3+细胞部分中,体外可克隆的B淋巴细胞前体细胞并未富集。此外,给成年骨髓中的B淋巴细胞前体细胞施用针对Flt3和c-Kit的拮抗单克隆抗体,并未阻断其增殖,这表明Flt3和c-Kit受体介导的信号传导对于成年小鼠骨髓中B细胞祖细胞的增殖并非必不可少。